Stock 300529 JAFRON BIOMEDICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jafron Biomedical Co.,Ltd.

Equities

300529

CNE100002995

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-09 EDT 		5-day change 1st Jan Change
29.3 CNY -0.10% Intraday chart for Jafron Biomedical Co.,Ltd. +6.39% +31.80%
04-26 Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 CI
04-25 Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 30,077 54,196 42,653 24,741 17,755 22,692 - -
Enterprise Value (EV) 1 30,077 54,196 42,653 24,741 17,755 22,692 22,692 22,692
P/E ratio 52.8 x 62.8 x 35.8 x 27.4 x 39 x 29.3 x 23.3 x 17.1 x
Yield - 0.97% - - - - - -
Capitalization / Revenue 21 x 27.8 x 15.9 x 9.93 x 9.24 x 7.87 x 6.59 x 4.82 x
EV / Revenue 21 x 27.8 x 15.9 x 9.93 x 9.24 x 7.87 x 6.59 x 4.82 x
EV / EBITDA 42.3 x 54 x 29 x 22.7 x 27.2 x 23.1 x 17.5 x 13.7 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 14 x 19.3 x 13.3 x 7.24 x 5.93 x 5.99 x 4.95 x 3.81 x
Nbr of stocks (in thousands) 795,460 799,109 800,245 798,864 798,709 774,466 - -
Reference price 2 37.81 67.82 53.30 30.97 22.23 29.30 29.30 29.30
Announcement Date 20-02-05 21-03-31 22-04-11 23-03-30 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,432 1,951 2,675 2,491 1,922 2,884 3,446 4,708
EBITDA 1 711.1 1,003 1,472 1,089 652.5 982.5 1,296 1,652
EBIT 1 680.3 1,054 1,418 1,029 543.8 1,003 1,264 1,709
Operating Margin 47.52% 54.05% 53% 41.32% 28.29% 34.78% 36.67% 36.3%
Earnings before Tax (EBT) 1 671.3 1,032 1,407 1,017 521 980.3 1,245 1,686
Net income 1 570.8 875.2 1,197 889.5 436.5 808.3 1,017 1,379
Net margin 39.87% 44.87% 44.73% 35.7% 22.71% 28.03% 29.53% 29.29%
EPS 2 0.7158 1.080 1.490 1.130 0.5700 1.000 1.260 1.710
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - 0.6600 - - - - - -
Announcement Date 20-02-05 21-03-31 22-04-11 23-03-30 24-04-25 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 Q3
Net sales 1 572.6 439.6 473.8
EBITDA - - -
EBIT - - -
Operating Margin - - -
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Dividend per Share - - -
Announcement Date 23-04-27 23-08-18 23-10-27
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 30.2% 35.7% 38.1% 26.3% 13.1% 22.7% 23.1% 24.7%
ROA (Net income/ Total Assets) - 30.6% - - - 13.9% 14.9% -
Assets 1 - 2,856 - - - 5,815 6,828 -
Book Value Per Share 2 2.690 3.510 4.020 4.280 3.750 4.890 5.920 7.700
Cash Flow per Share 2 0.7300 1.200 1.550 1.090 1.140 1.070 1.380 1.740
Capex 1 - 356 536 469 235 288 331 188
Capex / Sales - 18.26% 20.05% 18.82% 12.21% 10% 9.62% 4%
Announcement Date 20-02-05 21-03-31 22-04-11 23-03-30 24-04-25 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Jafron Biomedical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.3 CNY
Average target price
30.94 CNY
Spread / Average Target
+5.61%
Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
JAFRON BIOMEDICAL CO.,LTD. Stock Jafron Biomedical Co.,Ltd.
+31.80% 3.14B
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.84% 182B
MEDTRONIC PLC Stock Medtronic plc
+0.56% 110B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-3.35% 68.11B
DEXCOM, INC. Stock DexCom, Inc.
+2.39% 50.53B
CENCORA, INC. Stock Cencora, Inc.
+9.36% 44.8B
HOYA CORPORATION Stock Hoya Corporation
+2.70% 40.7B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+3.43% 26.53B
TERUMO CORPORATION Stock Terumo Corporation
+13.67% 25.02B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-0.32% 24.96B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 300529 Stock
  4. Financials Jafron Biomedical Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW